RenovoRx (RNXT) Other Working Capital Changes (2020 - 2026)
RenovoRx (RNXT) posted Other Working Capital Changes of -$19000.0 for Q1 2026, up 13.64% sequentially from -$22000.0 in Q4 2025, and down 113.48% YoY from $141000.0 in Q1 2025.
RenovoRx (RNXT) Other Working Capital Changes (2020 - 2026) Analysis & Trends
RenovoRx has reported Other Working Capital Changes for 7 years, with the latest figure at -$19000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 113.48% year-over-year to -$19000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$160000.0 (down 151.78% YoY) and the FY2024 annual result came in at $221000.0, up 134.91% from the prior year.
- Other Working Capital Changes grew to -$19000.0 in Q1 2026 per RNXT's latest filing, from -$22000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $658000.0 in Q3 2022 and troughed at -$344000.0 in Q2 2022.
- A 5-year average of -$25882.4 and a median of -$55000.0 in 2024 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes plunged 26800.0% in 2022, then jumped 412.5% in 2024.
- Over 5 years, Other Working Capital Changes stood at -$56000.0 in 2022, then retreated by 7.14% to -$60000.0 in 2023, then climbed by 8.33% to -$55000.0 in 2024, then soared by 60.0% to -$22000.0 in 2025, then advanced by 13.64% to -$19000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$19000.0, -$22000.0, and -$80000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.84 Bn | 131.99 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.48 Bn | 78.49 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 60.15 Bn | 55.01 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.54 Bn | 10.14 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.22 Bn | 26.38 Bn | - |
| 10 | RenovoRx | 61.70 Mn | 61.70 Mn | 766,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -45,000.00 |
| Jun 30, 2026 | -45,000.00 |
| Jun 30, 2026 | -45,000.00 |
| Mar 31, 2026 | -19,000.00 |
| Mar 31, 2026 | -19,000.00 |
| Mar 31, 2026 | -19,000.00 |
| Dec 31, 2025 | -22,000.00 |
| Dec 31, 2025 | -22,000.00 |
| Dec 31, 2025 | -22,000.00 |
| Sep 30, 2025 | -80,000.00 |
| Sep 30, 2025 | -80,000.00 |
| Sep 30, 2025 | -80,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Mar 31, 2025 | 141,000.00 |
| Mar 31, 2025 | 141,000.00 |
| Mar 31, 2025 | 141,000.00 |
| Dec 31, 2024 | -55,000.00 |
| Dec 31, 2024 | -55,000.00 |